Abstract
Before a molecular test is implemented for reporting patient results, it is the responsibility of the laboratory to validate or verify, as well as to document, the performance characteristics of the assay. Such performance characteristics relate to the accuracy, precision, and robustness of the test in measuring the analyte for the intended purposes of the test. Assay validation is an extensive process that has to conform to the standards, as determined by regulations such as the ones passed by the US Congress in 1988: the Clinical Laboratory Improvement Amendments (CLIA-’88). The standards implemented by CLIA-’88 were designed to ensure the accuracy and reliability of human patient testing results regardless of where the test was performed. CLIA-’88 regulations established different complexity levels of laboratory tests. As such, laboratory testing is divided into simple or “waived” tests, tests of moderate complexity, and high complexity tests. All molecular tests fall within the “high-complexity” category as defined by CLIA-’88 [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Medicare. Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)-HCFA. Final rule with comment period. Fed Regist. 1992;57:7002–186.
Ferreira-Gonzalez A, Emmadi R, Day SP, et al. Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology. J Mol Diagn. 2014;16:3–6.
Clinical and Laboratory Standards Institute. Establishing molecular testing in clinical laboratory environments: approved guideline. CLSI document MM19-A. Wayne, PA: CLSI; 2011.
Clinical and Laboratory Standards Institute. Molecular diagnostic methods for genetic diseases: approved guideline. CLSI document MM1-A2. 2nd ed. Wayne, PA: CLSI; 2006.
Clinical and Laboratory Standards Institute. Nucleic acid sequencing methods in diagnostic laboratory medicine: approved guideline. CLSI document MM09-A2. 2nd ed. Wayne, PA: CLSI; 2014.
Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative analytical methods: approved guideline. CLSI document EP6-A. Wayne, PA: CLSI; 2003.
Clinical and Laboratory Standards Institute. Verification and validation of multiplex nucleic-acid assays: approved guideline. Document MM17-A. Wayne, PA: CLSI; 2008.
Jennings L, Van Deerlin VM, Gulley ML. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med. 2009;133:743–55.
Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. 2010;23:550–76.
Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol. 2000;53:666–72.
Dumur CI, Sana S, Ladd AC, et al. Assessing the impact of tissue devitalization time on genome-wide gene expression analysis in ovarian tumor samples. Diagn Mol Pathol. 2008;17:200–6.
Baloglu G, Haholu A, Kucukodaci Z, et al. The effects of tissue fixation alternatives on DNA content: a study on normal colon tissue. Appl Immunohistochem Mol Morphol. 2008;16:485–92.
Clinical and Laboratory Standards Institute. Evaluation of matrix effects: approved guideline. CLSI document EP14-A2. 2nd ed. Wayne, PA: CLSI; 2005.
Clinical and Laboratory Standards Institute. User verification of performance for precision and trueness: approved guideline. CLSI document EP15-A3. 3rd ed. Wayne, PA: CLSI; 2014.
Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement procedures: approved guideline. CLSI document EP5-A3. 3rd ed. Wayne, PA: CLSI; 2014.
Clinical and Laboratory Standards Institute. Evaluation of detection capability for clinical laboratory measurement procedures: approved guideline. CLSI document EP17-A2. 2nd ed. Wayne, PA: CLSI; 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Dumur, C.I. (2015). General Principles of Validating a Molecular Test. In: Idowu, M., Dumur, C., Garrett, C. (eds) Molecular Oncology Testing for Solid Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-16304-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-16304-8_6
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16303-1
Online ISBN: 978-3-319-16304-8
eBook Packages: MedicineMedicine (R0)